FDA Clearance of Aptima BV and Aptima CV/TV Molecular Assays Ushers in New Era of Comprehensive and Objective Diagnostic Testing for Vaginitis - Odessa American

FDA Clearance of Aptima BV and Aptima CV/TV Molecular Assays Ushers in New Era of Comprehensive and Objective Diagnostic Testing for Vaginitis  Odessa American

Hologic, Inc. (Nasdaq: HOLX) announced today that the FDA has granted clearance for its new Aptima ® BV and Aptima ® CV/TV assays, which provide an ...